Stock Screener: Medical , Medical-Biomed-Genetics

The medical or healthcare sector comprises of those stocks which are involved in the production of medical goods.
Medical-Biomed-Genetics belongs to the sector Medical. This industry has a Market Cap of 685.33B. The top rated companies for Medical-Biomed-Genetics industry are: Amgen (AMGN) , Gilead Sciences (GILD) , Celgene (CELG).

Select Sector Select Industry
Click on the column to sort the table.
Company Stock Rating Market Cap PE Ratio 1W 52W
Amgen (AMGN)
4.3/5 116.14B 15.58 -1.71% 3.19%
Biogen Inc (BIIB)
4.3/5 61.48B 16.09 -4.77% 4.18%
Anika Therapeutics (ANIK)
4.2/5 731.59M 21.47 -1.42% 31.31%
Gilead Sciences (GILD)
4.1/5 96.27B 6.78 -3.65% -20.44%
Regeneron Pharma (REGN)
3.9/5 38.83B 54.54 3.69% -20.48%
AMAG Pharma (AMAG)
3.9/5 786.83M 58.97 0 -0.39
China Biologic Products (CBPO)
3.9/5 2.96B 29.97 -3.65% -13.3%
Celgene (CELG)
3.8/5 91.07B 44.50 -2.27% 13.99%
Cambrex (CBM)
3.7/5 1.8B 29.71 -0.36% 33.58%
Myriad Genetics (MYGN)
3.7/5 1.12B 14.20 -7.48% -59.35%
PDL BioPharma (PDLI)
3.7/5 375.78M 2.14 0 -26.77
Enzo Biochem (ENZ)
3.7/5 329.12M 8.46 0.85% 57.3%
Alexion Pharma (ALXN)
3.7/5 30.66B 84.01 -5.42% -13.71%
Innoviva (INVA)
3.6/5 1.23B 33.38 -2.49% 25.41%
Emergent Biosolutions (EBS)
3.6/5 1.24B 30.97 -4.31% -11.46%
BioTechne Corporation (TECH)
3.6/5 3.78B 38.70 -1.79% 21.69%
Incyte (INCY)
3.6/5 22.18B 150.96 -0.65% 53.02%
Illumina (ILMN)
3.5/5 23.88B 54.37 14.86% -5.01%
Five Prime Therapeutics (FPRX)
3.3/5 1.39B 5.45 -6.77% 44.62%
Integra LifeSciences (IART)
3.3/5 3.18B 55.18 -4.94% 35.19%
Qiagen (QGEN)
3.3/5 6.8B 57.86 -1.29% 29.33%
Horizon Pharma (HZNP)
3.3/5 2.81B - -1.8% -5.12%
Repligen (RGEN)
3.3/5 1.05B 154.65 -4.36% 37.83%
ANI Pharma (ANIP)
3.2/5 688.89M 86.22 -4.23% 66.78%
Ligand Pharma (LGND)
3.2/5 2.21B 310.65 -1.87% 8.77%
Applied Genetic Technologies (AGTC)
3.2/5 169.84M 14.92 -3.59% -39.55%
Osiris Therapeutics (OSIR) 3.1/5 169.16M 78.00 -0.2% -32.55%
Heska (HSKA)
3.1/5 531.77M 61.67 4.15% 126.8%
MiMedx (MDXG)
3.0/5 960.45M 48.72 1.74% 2.93%
NeoGenomics (NEO)
2.6/5 675.21M - -1.83% 22.33%
Exelixis (EXEL)
2.6/5 5.3B - 5.29% 337.59%
Retrophin (RTRX)
2.6/5 736.91M - -0.61% 15.7%
Vertex Pharma (VRTX)
2.5/5 20.63B - 0.37% -15.05%
Cytokinetics (CYTK)
2.5/5 481.3M - -9.2% 35.89%
Genomic Health (GHDX)
2.4/5 979.26M - 0.17% -1.32%
Alkermes (ALKS)
2.4/5 8.43B - -7.44% -11.06%
Seattle Genetics (SGEN)
2.4/5 8.37B - 0.53% 64.13%
Acorda Therapeutics (ACOR)
2.4/5 986.84M - 0.47% -46.37%
Vanda Pharmaceuticals (VNDA)
2.4/5 626.24M - -3.06% 61.38%
BioMarin Pharma (BMRN)
2.3/5 14.95B - -4.51% 4.55%
Lexicon Pharma (LXRX)
2.3/5 1.53B - 1.24% 43.48%
Kamada (KMDA)
2.3/5 223.07M - 2.08% 54.67%
Amarin (AMRN)
2.2/5 815.26M - -0.98% 102.01%
Organovo (ONVO)
2.2/5 384.3M - -1.86% 96.81%
Halozyme Therapeutics (HALO)
2.2/5 1.47B - -20.01% 12.77%
Array BioPharma (ARRY)
2.2/5 1.83B - 15.64% 221.6%
Galapagos (GLPG)
2.1/5 3.2B - 0.73% 35.14%
Momenta Pharma (MNTA)
2.1/5 1.15B - -0.92% 23.85%
Geron (GERN)
2.1/5 335.8M - -4.52% -36.83%
Sinovac Biotech (SVA)
2.1/5 342.35M - 0.33% 19.01%
Nymox Pharmaceutical (NYMX)
2.1/5 138.56M - 6.38% 36.36%
EXACT Sciences (EXAS)
2.1/5 2.06B - 5.9% 187.61%
Cellectis (CLLS)
2.1/5 639.19M - -3.38% -19.62%
Keryx Biopharma (KERX)
2.1/5 663.31M - 1.62% 90.27%
Aduro BioTech (ADRO)
2.1/5 826.34M - 2.93% -40.55%
Coherus Biosciences (CHRS)
2.1/5 1.19B - -1.81% 67.7%
VIVUS (VVUS)
2.0/5 125.81M - -5.51% 15.38%
Regenxbio (RGNX)
2.0/5 517.68M - 0.77% 55.16%
Uniquire (QURE)
2.0/5 150.36M - 1.36% -62.39%
Inovio Pharma (INO)
2.0/5 516.95M - -3.72% 33.97%
Arna Pharma (ARNA)
2.0/5 345.63M - -4.05% -13.94%
Athersys (ATHX)
2.0/5 129.1M - -1.31% 33.63%
NewLink Genetics (NLNK)
1.9/5 350.2M - -8.38% -53.07%
Curis (CRIS)
1.9/5 417.43M - -4.81% 57.98%
Compugen (CGEN)
1.9/5 254.54M - -4.76% -1.57%
Alnylam Pharma (ALNY)
1.8/5 3.57B - -4.37% -45.25%
Sorrento Therapeutics (SRNE)
1.8/5 287.49M - 0 -4.72
Evogene (EVGN)
1.8/5 140.91M - 7.38% -23.19%
The Medicines Company (MDCO)
1.8/5 2.7B - 5.98% 20.06%
Arbutus Biopharma (ABUS)
1.8/5 164.53M - 1.69% -18.92%
Celldex Therapeutics (CLDX)
1.8/5 435.01M - -7.38% -67.32%
Intercept Pharma (ICPT)
1.8/5 2.84B - 8.25% -6.02%
Acceleron Pharma (XLRN)
1.8/5 963.68M - -3.88% -24.22%
Spark Therapeutics (ONCE)
1.8/5 1.76B - -8.58% 94.32%
Immunomedics (IMMU)
1.7/5 428.01M - 16.09% 107.18%
Merrimack Pharma (MACK)
1.7/5 416.07M - -12.53% -47.89%
Juno Therapeutics (JUNO)
1.7/5 2.12B - -1.67% -40.92%
Cellular Biomedicine (CBMG)
1.7/5 186.69M - -1.5% 6.5%
Mesoblast (MESO)
1.7/5 500.41M - 3.99% 12.03%
Stemline Therapeutics (STML)
1.7/5 248.11M - -1.89% 166.46%
Blueprint Medicines (BPMC)
1.7/5 1.05B - 1.4% 83.88%
Kite Pharma (KITE)
1.7/5 2.47B - -4.9% -11.13%
Ophthotech (OPHT)
1.7/5 173.49M - 0.21% -92.39%
ZIOPHARM Oncology (ZIOP)
1.6/5 798.3M - 5.39% 2.02%
Idera Pharma (IDRA)
1.6/5 233.29M - -2.47% -20.2%
Adverum (ADVM)
1.6/5 131.41M - 3.28% -48.11%
Cara Therapeutics (CARA)
1.6/5 311.57M - 2.88% -4.44%
Agenus (AGEN)
1.6/5 356.35M - -1.45% 29.43%
Acadia Pharma (ACAD)
1.6/5 3.85B - -2.81% 33.6%
CytomX Therapeutics (CTMX)
1.6/5 421.9M - 3.3% -12.53%
bluebird bio (BLUE)
1.6/5 2.71B - -2.98% 49.53%
Achillion Pharma (ACHN)
1.5/5 574.06M - -6.04% -44.44%
Argos Therapeutics (ARGS)
1.5/5 222.82M - -1.82% 171.36%
Prothena (PRTA)
1.5/5 1.74B - -7.01% 10.24%
OncoMed Pharma (OMED)
1.5/5 298.22M - -7.59% -49.24%
Abeona Therapeutics (ABEO)
1.5/5 211.79M - -12.4% 89.96%
Epizyme (EPZM)
1.5/5 661.33M - -4.6% 14.8%
Revance (RVNC)
1.5/5 624.48M - -4.58% -9.28%
Dynavax Technologies (DVAX)
1.4/5 167.6M - 1.16% -79.33%
Vtv Therapeutics (VTVT)
1.4/5 176.86M - 8.02% -18.95%
Sangamo BioSciences (SGMO)
1.4/5 310.75M - 18.92% -29.82%
Pluristem Therapeutics (PSTI)
1.4/5 126.39M - 6.12% 95%
Dimension Therapeutics (DMTX)
1.4/5 120.21M - 11.63% -41.1%
MediciNova (MNOV)
1.4/5 214.7M - 3.15% 67.2%
MyoKardia (MYOK)
1.4/5 429.01M - -1.8% 26.27%
NantKwest (NK)
1.4/5 532.14M - -2.42% -48.11%
Adaptimmune Therapeutics (ADAP)
1.3/5 320.66M - 11.3% -40.86%
Sarepta Therapeutics (SRPT)
1.3/5 2.07B - 21.02% 164.92%
Ascendis Pharma (ASND)
1.3/5 657.61M - 1.21% 23.87%
Xenon Pharma (XENE) 1.3/5 149.41M - -1.18% 8.87%
MannKind (MNKD)
1.3/5 327.83M - 8.73% -26.19%
Alder BioPharma (ALDR)
1.3/5 1.07B - -4.26% -26.71%
Insmed (INSM)
1.3/5 952.92M - 8.3% 7.69%
Amicus Therapeutics (FOLD)
1.3/5 849.02M - 7.4% -19.16%
Paratek Pharma (PRTK)
1.3/5 349.6M - -2.83% -2.4%
Novavax (NVAX)
1.3/5 387.88M - 0.7% -78.03%
Advaxis (ADXS)
1.3/5 370.56M - 9.62% 26.96%
Trevena (TRVN)
1.2/5 356M - -2% -20.05%
Beigene (BGNE)
1.2/5 1.03B - 3.68% 15.43%
Intra-Cellular Therapies (ITCI)
1.1/5 645.99M - -10.97% -67.12%
Tengion (TNGNQ) - 0.06M - 100 0
Bionovo (BNVIQ) - 0.02M - 0 0
Protein Polymer (PPTIQ) - 0.06M - 0 0
Gliatech (GLIAQ) - 0M - N/A N/A
Cellcyte Genetics (CCYG) - 0.25M - 50% -25%
Viralytics (VRACY) - 160.99M - 0 36.73
Cormedix (CRMD) - 72.77M - 1.12% 46.34%
Williston Holding (WHCA) - 3.93M - 0 900
Neuro Hitech (NHPI) - 0M - 0 0
Igene Biotechnology (IGNE) - 1.1M - 0 0
IR Biosciences (IRBS) - 0M - 0 -100
Advanced Life Sciences (ADLS) - 0M - -100% -100%
Biocoral (BCRA) - 1.23M - N/A N/A
BioTime (BTX) - 357.74M 16.48 -4.68% 32.06%
Palatin Technologies (PTN) - 58.85M - -15.19% -20.83%
Regenicin (RGIN) - 21.33M - -0.71% 595%
Genitope (GTOPQ) - 0.06M - 0 0
ZYTO Corp (ZYTO) - 1.25M - 20% 20%
Mast Therapeutics (MSTX) - 34.93M - -8.67% -65.32%
Deltagen (DGEN) - 0M - 0 -100
Helix Biomedix (HXBM) - 7.85M - 0 0.64
USA Equities Corp (USAQ) - 0.03M - 0 -97.5
Marina Biotech (MRNA) - 15.25M - -10.53% -15%
AtheroNova (AHROQ) - 0.08M - 0 50
Nanobac Pharma (NNBP) - 0.07M - 0 0
Asterias Biotherapeutics (AST) - 226.43M - 4.3% 74.46%
Akesis Pharma (AKESQ) - 0.03M - N/A N/A
Bellus Health (BLUSF) - 12.46M - -4.23% -71.67%
Oncolytics Biotech (ONCYF) - 26.93M - 2.3% -18.08%
Protalix Biotherapeutics (PLX) - 42.97M - 2.38% -47.56%
Redpoint Bio (RPBC) - 0.07M - 0 -50
Health Discovery (HDVY) - 1.9M - -65% -79.41%
Respirerx Pharma (RSPI) - 7.98M - 13.51% -42.24%
NeurogesX (NGSX) - 0.17M - -37.5% -28.57%
HedgePath Pharma (HPPI) - 141.37M - 17.65% 300%
iBio (IBIO) - 35.64M - 2.56% -28.57%
Amarillo (AMAR) - 5.99M - 0 75
Myrexis (MYRX) - 1.52M - -12% -50.56%
Introgen Therapeutics (INGNQ) - 0M - N/A N/A
Insite Vision (INSV) - 45.85M - N/A N/A
Synthetic Biologics (SYN) - 101.29M - -1.92% -46.09%
PROTAGENIC THER (PTIX) - 51.31M - -35.33% 61.71%
Immune Therapeutics (IMUN) - 12.95M - 20% -74.29%
Biocurex (BOCX) - 0M - N/A N/A
Panacos Pharma (PANC) - 0.01M - 0 0
Response Genetics (RGDXQ) - 0.05M - 0 -66.67
Genmab (GNMSF) - 10.92B 108.38 0 44.8
Cel-Sci Corporation (CVM) - 23.97M - 10.43% -70.47%
Nicox (NICXF) - 257.55M - 0 3.1
Pfenex (PFNX) - 211.23M 29.10 -5.45 0
Interleukin Genetics (ILIU) - 25.05M - 9% 118%
US Stem Cell (USRM) - 0.14M - 0 -99.75
International Stem Cell Corp (ISCO) - 4.05M - 1.98% -61.85%
Affymax (AFFY) - 2.21M - -9.23% -28.92%
Theratechnologies (THERF) - 160.47M 281.25 0.54% 127.27%
BioForce Nanosciences (BFNH) - 0.28M - 0 -54.17
Capstone Therapeutics Corp. (CAPS) - 3.88M - -5% -20.83%
Pathfinder Cell (PFND) - 0.67M - -50% -75%
Provectus Biopharma (PVCT) - 4.27M - 0 -95.31
Regenerx Biopharma (RGRX) - 33.1M - -6.06% -23.83%
Guangzhou Pharma (GZPHY) - 726.88M - 0 0
VG Life Sciences (VGLS) - 0.79M - -30% -63.16%
Clovis Oncology (CLVS) - 2.46B - 9.04% 146.27%
Volitionrx (VNRX) - 112.98M - -15.1% 8.79%
DNAPrint Genomics (DNAG) - 0.06M - 0 0
Savient Pharma (SVNTQ) - 0.59M - N/A N/A
Taxus Cardium Pharma (CRXM) - 2.46M - 11.88% -34.91%
GeneLink (GNLKQ) - 0.21M - 0 0
Nutra Pharma (NPHC) - 2.22M 1.29 0 -64
Atara Bio (ATRA) - 427.14M - -9.76% -29.12%
ImmunoCellular Therapeutics (IMUC) - 9.52M - 26.26% -72.8%
DBV Tech (DBVT) - 1.72B - 0.97% 31.22%
ARYx Therapeutics (ARYX) - 0.13M - -20% 33.33%
Arbutus Biopharma (ABUS)
- 164.53M - 1.69% -18.92%
Actelion (ALIOF) - 24.8B - 2.29% 84.3%
Prodite Pharma (PPMD) - 0.12M - 0 -25
Ampliphi Biosciences (APHB) - 5.67M - 5.81% -82.11%
Quick-Med Technologies (QMDT) - 0.29M - 0 -33.33
SCOLR Pharma (SCLR) - 0.04M - N/A N/A